FDA NDC Directory · JSON-LD · Markdown

ELFABRIO

NDC 10122-165 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic namepegunigalsidase alfa
Labeler / ManufacturerChiesi USA, Inc.
Marketing categoryBiologic License Application · App BLA761161
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsPEGUNIGALSIDASE ALFA (5 mg/2.5mL)
Marketing started20230523
Package count1

External sources

Source: openFDA. Public-domain (CC0).